




版權說明:本文檔由用戶提供并上傳,收益歸屬內容提供方,若內容存在侵權,請進行舉報或認領
文檔簡介
TheEpidemiologyofSepsisintheUnitedStatesfrom1979through2000NEnglJMed2003;348:1546-1554現在是1頁\一共有59頁\編輯于星期二Long-termmortalityandmedicalcarechargesinpatientswithseveresepsis.CritCareMed.
2003
Sep;31(9):2316-23.Cumulativemortalityrateamongpatientswithseveresepsis現在是2頁\一共有59頁\編輯于星期二DistributionofvariousmicroorganismsandsitesofinfectioninseveresepsispatientsandtheoutcomeaccordingtothemicroorganismsandsitesofinfectioninseveresepsispatientsCritCareMed2007;35:2538-2546EpidemiologyofseveresepsisincriticallyillsurgicalpatientsintenuniversityhospitalsinChina現在是3頁\一共有59頁\編輯于星期二CharacteristicsofcriticallyillpatientsinICUsinmainlandChina
CritCareMed.
2013
Jan;41(1):84-92PatientOutcomeandRiskFactors
Therewere1,034survivors:986(76.0%)weredischargedhome,and48(3.7%)werestillinthehospitalonNovember30,2009.Therewere263nonsurvivors(20.3%):211diedintheICU,andtheother52diedinthegeneralwards.BinDu,MD;YouzhongAn,MD;YanKang,MDetal;現在是4頁\一共有59頁\編輯于星期二2004年,11個國際醫(yī)學組織的感染和膿毒癥診治方面的專家,出版了第一個改進重癥膿毒癥和膿毒癥休克預后的指南。這個工作組聯合其他工作組在2006年和2007年再次舉行會議,用新的循證方法論系統(tǒng)來評估證據的質量和推薦力度,以更新該指南文件。這些建議的目的是用來指導臨床醫(yī)生治療重癥膿毒癥和膿毒癥性休克的病人。需要指出的是,當醫(yī)生面對具體病人獨特的臨床指標時,這些指南中的建議不能取代臨床醫(yī)生的決策?,F在是5頁\一共有59頁\編輯于星期二2008201211個國際組織15個國際組織29個國際組織44位委員55位委員69位委員135篇參考文獻341篇參考文獻636篇參考文獻現在是6頁\一共有59頁\編輯于星期二Chest.1992Jun;101(6):1644-55不足之處:標準存在的敏感性高但特異性差的問題
ACCP/SCCM1992Definitionsforsepsisandorganfailureandguidelinesfortheuseofinnovativetherapiesinsepsis現在是7頁\一共有59頁\編輯于星期二NewdiagnosticCriteriaforSepsis:2012CritCareMed.2013Feb;41(2):580-637.現在是8頁\一共有59頁\編輯于星期二NewdiagnosticCriteriaforSepsis:2012CritCareMed.2013Feb;41(2):580-637.現在是9頁\一共有59頁\編輯于星期二Onecase:女性,85歲,住院號:2260073主訴:患者系“反復咳嗽、咳痰三年,加重一周”入院入院時間:2013年3月26日轉入時間:2013年4月05日診療過程:入我院干部病房后出現發(fā)熱現象,同時伴有胸悶、氣喘加重,痰培養(yǎng)示細菌(嗜麥芽窄食假單胞菌及熱帶念珠菌);2012年5月行肺CT檢查示“間質性肺炎”現在是10頁\一共有59頁\編輯于星期二Onecase:女性,85歲,住院號:22600732013年4月5日出現呼吸困難加重,氧飽和度下降至82%,予以積極的對癥處理后,癥狀不能改善,故轉入我科加強治療。現在是11頁\一共有59頁\編輯于星期二轉入后檢查急診生化K5.05mmol/L,Na141.1mmol/L,CL113.0mmol/L,Ca1.46mmol/L,CREA248.4umol/LCO215.8mmol/L,AG17.30,GLU3.01mmol/L,ALB16.3g/L
現在是12頁\一共有59頁\編輯于星期二入科診斷:重癥醫(yī)院獲得性肺炎(吸入性);感染性休克?;呼吸衰竭(I型);間質性肺疾病(IPF/IIP);3級高血壓,極高危;老年性癡呆;慢性腎衰竭。診療計劃:1、一般治療,糾正休克;2、氣管插管、機械通氣(輕度鎮(zhèn)痛鎮(zhèn)靜);3、抗感染治療(頭孢哌酮舒巴坦2.0靜脈滴注q12h;滅滴靈注射液0.5g靜脈滴注bid;);4、補液、營養(yǎng)支持及維持水電解質平衡等對癥支持處理;血氣分析+乳酸:
PH7.072,PCO232.6mmHg,PO247.2mmHg,ABE-19.1mmol/LSBE-19.0mmol/L,Lac5.5mmol/L。CURB-65評分:4分同時,進一步完善病原學診斷(血培養(yǎng),痰培養(yǎng)等)現在是13頁\一共有59頁\編輯于星期二BecauseinvasionofthelungparenchymabyCandidaspecieswithresultingCandidapneumoniaisarareevent,controversysurroundsthisentity.Infact,theisolationofcandidalspeciesfromrespiratorysecretionsismostoftennotclinicallysignificant.AmJRespirCritCareMed.2011Jan1;183(1):96-128.AnofficialAmericanThoracicSocietystatement:Treatmentoffungalinfectionsinadultpulmonaryandcriticalcarepatients.AtMemorialHospitalandNewYorkHospital,30patients.TheCandidapulmonarydiseaseappearedtobesignificantclinicalfactorinonlythreecases.PulmonarydiseasecausedbyCandidaspecies.AmJMed.1977Dec;63(6):914-25.Todate,fewdataareavailableontheCandidaspeciesthatcausePC,Itisofnotethatinourseries,thevariousnon-albicansspeciesofCandidadidnotappeartobemorelikelytocausePCthanisCandidaalbicans.Pulmonarycandidiasisinpatientswithcancer:anautopsystudy.ClinInfectDis.2002Feb1;34(3):400-3.Epub2001Dec17.現在是14頁\一共有59頁\編輯于星期二ANCA:C-ANCA(-)及P-ANCA(-)尿常規(guī):陰性現在是15頁\一共有59頁\編輯于星期二4月07日4月08日4月09日4月10日4月11日4月12日4月13日升壓藥物去甲腎難以撤除,尿量逐漸減少調整抗生素(替考拉寧)?現在是16頁\一共有59頁\編輯于星期二轉入后檢查復查床邊胸片無明顯進展性改變?,F在是17頁\一共有59頁\編輯于星期二Itisaclinicalsyndromeinwhichfocalinfiltratesbeginwithsomeclinicalassociationofacutepulmonaryinfection(i.e.fever,expectoration,malaise,ordyspnea)anddespiteaminimumof10daysofantibiotictherapypatientseitherdonotimproveorworsenclinicallyorradiographicopacitiesfailtoresolvewithin12weeksoftheonsetofthepneumonia.Nonresolvingpneumonia(無反應性肺炎)CurrOpinPulmMed.
2005May;11(3):247-52.Progressiveand
nonresolving
pneumonia.Nonresolvingpneumoniadefinitions(無反應性肺炎)Failuretorespondtoantimicrobialtreatmentwasclassifiedasnonrespondingorprogressivepneumonia.Nonrespondingpneumoniawasdefinedaspersistingfever>38℃and/orclinicalsymptoms(malaise,cough,expectoration,dyspnea)afteratleast72hofantimicrobialtreatment.現在是18頁\一共有59頁\編輯于星期二Antimicrobialtreatmentfailuresinpatientswithcommunity-acquiredpneumonia:causesandprognosticimplications.AmJ
Respir
Crit
Care
Med.
2000
Jul;162(1):154-60.444patients,49patients(11%)hadarepeatedinvestigationbecauseofantimicrobialtreatmentfailure.Considerationswhenapatientwithcommunity-acquiredpneumoniaisnotimproving現在是19頁\一共有59頁\編輯于星期二1、女性,85歲;2、“反復咳嗽、咳痰三年,加重一周伴胸悶、氣喘”,長期服用抗生素及激素;3、抗生素治療效果差(無反應);4、CD4/CD8=1.1總結分析病史特點:診斷:無反應性肺炎現在是20頁\一共有59頁\編輯于星期二Results:Treatmentfailureoccurredin215patients(15.1%):134earlyfailure(62.3%)and81latefailure(37.7%).Thecauseswereinfectiousin86patients(40%),non-infectiousin34(15.8%).Thorax.
2009
Nov;59(11):960-5.Riskfactorsoftreatmentfailureincommunityacquiredpneumonia.Themaincausesofearlyfailurewereprogressivepneumonia(n=54),pleuralempyema(n=18)lackofresponse(n=13),anduncontrolledsepsis(n=9).ArchInternMed.
2010
Mar8;164(5):502-8.CausesandfactorsassociatedwithearlyfailureinhospitalizedpatientswithCAP現在是21頁\一共有59頁\編輯于星期二Results:Thefollowingshowedtheprevalenceratesofthecauses:infection41.7%,unknowncauses50.0%,non-infectiouscauses8.3%.DiagnosisandTreatmentofNonrespondingPneumoniaPatientsPJCCPVDJanuary2012,Vol,20No.1(顧靖華)現在是22頁\一共有59頁\編輯于星期二進一步完善相關檢查現在是23頁\一共有59頁\編輯于星期二重癥醫(yī)學科(ICU)患者是侵襲性真菌感染(IFI)的高發(fā)人群,并日益成為導致ICU患者死亡的重要病因之一。ICU患者最突出的特點:解剖生理屏障完整性的破壞。
《重癥患者侵襲性真菌感染診斷和治療指南》中華醫(yī)學會重癥醫(yī)學分會現在是24頁\一共有59頁\編輯于星期二NEnglJMed2003;348:1546-1554TheEpidemiologyofSepsisintheUnitedStatesfrom1979through2000IntJAntimicrobAgents.2008;32:S87-91Epidemiologyofcandidemiainintensivecareunits現在是25頁\一共有59頁\編輯于星期二外周靜脈CVC血培養(yǎng)檢查結果(微生物室電話提前報,5月9日下午)BDG=102pg/mlThe
University
of
Virginiariskfactorsscoringsystem:36現在是26頁\一共有59頁\編輯于星期二NosocomialBloodstreamInfectionsinUSHospitals:Analysisof24,179CasesfromaProspectiveNationwideSurveillanceStudy.ClinInfectDis.
2004Aug1;39(3):309-17.
現在是27頁\一共有59頁\編輯于星期二107(39.5%)patientswithisolatedcandidemia,77(28.4%)withinvasivecandidiasis.In37%ofthecases,candidemiaoccurredwithinthefirst5daysafterICUadmission.CritCareMed.
2009
May;37(5):1612-8OnehundredeightyICUsinFrance現在是28頁\一共有59頁\編輯于星期二AnnSurg.
2001Apr;233(4):542-8.
PelzRK,
HendrixCW,
SwobodaSM,
現在是29頁\一共有59頁\編輯于星期二IntJAntimicrobAgents.
2009
Sep;34(3):205-9ConsensusstatementonthemanagementofinvasivecandidiasisinICUintheAsia-PacificRegion現在是30頁\一共有59頁\編輯于星期二CHINASCANteamNonalbicans>54.7%C.albicans41.8%mixedinfectionotherCandidaspeciesDiagnosticconfirmationwasbasedsolelyonatleastonepositivebloodculturein290(94.8%)casesDiagnosiswasconfirmedbyhistopathologyinonepatient(0.3%)InvasivecandidiasisinintensivecareunitsinChina:amulticentreprospectiveobservationalstudy.JAntimicrobChemother.2013Mar29.1-9FengmeiGuo1,YiYang1,YanKang,etal.現在是31頁\一共有59頁\編輯于星期二CritCare.2008;12(1):R5Impactofinvasivefungalinfectiononoutcomesofseveresepsis:amul-
ticentermatchedcohortstudyincriticallyillsurgicalpatients現在是32頁\一共有59頁\編輯于星期二OutcomesofcandidemicsepticshockpatientscomparedwithbacteremicsepticshockpatientsCritCareMed.2002Aug;30(8):1808-14.現在是33頁\一共有59頁\編輯于星期二InternationalGuidelinesforManagementofSevereSepsisandSepticShock:2012whatactuallychangedaboutfungus?現在是34頁\一共有59頁\編輯于星期二Useofthe1,3beta-D-glucanassay(grade2B),mannanandanti-mannanantibodyassays(2C).Change1:Diagnosis現在是35頁\一共有59頁\編輯于星期二InternMed.
2011;50(22):2783-91Diagnosisofinvasivefungaldiseaseusingserum(1→3)-β-D-glucan:abivariatemeta-analysis.NOTE.AUC,theareaunderthesummaryreceiveroperatingcharacteristiccurve;CI,confidenceinterval;galactomannan,GM;IA,invasiveaspergillosis;IFD,invasivefungaldisease;NLR,negativelikelihoodratio;PLR,positivelikelihoodratio;SEN,sensitivity;SPE,specificity.PooledTestPerformanceoftheIncludedStudiesintheMeta-Analysis現在是36頁\一共有59頁\編輯于星期二InternalcontroldetectionwaspositiveforallsamplesthatwerenegativebyPCR.ThemediantimefromdiagnosticculturesforCandidatocollectionofsamplesforPCRandBDGwas4days(interquartilerange:1-6days).Abbreviations:BDG,1,3-b-D-glucan;PCR,polymerasechainreaction.aCandidemiaanddeep-seatedcandidiasisgroupsincluded5patientswhohadbothconditions.bDeep-seatedcandidiasisincludedpatientswithintra-abdominalinfectionsandinfectionsofothersites(boneanddevitalizedsurroundingtissue,n=2;lumbarspinedevice,n=1;cranialabscess,n=1).cPCRwaspositiveifpositiveresultwasobtainedonplasmaand/orsera.dPvaluesareforsensitivitiesoftherespectiveassays,asdeterminedbyMcNemartest.PerformanceofPolymeraseChainReactionand1,3-β-D-GlucanAssaysClinInfectDis.
2012May;54(9):1240-8.現在是37頁\一共有59頁\編輯于星期二Change2:DiagnosisUseoflowprocalcitoninlevelsorsimilarbiomarkerstoassisttheclinicianinthediscontinuationofempiricantibioticsinpatientswhoinitiallyappearedseptic,buthavenosubsequentevidenceofinfection(grade2C).DiagnMicrobiolInfectDis.2012Jul;73(3):221-7現在是38頁\一共有59頁\編輯于星期二AmJRespirCritCareMed.2001Aug1;164(3):396-402AreasundertheROCwere:PCT,0.92;IL-6,0.75;IL-8,0.71clinicalmodelwithPCT,0.94,andclinicalmodelwithoutPCT,0.77BaselinePlasmaLevelsofPCT,IL-6,andIL-8現在是39頁\一共有59頁\編輯于星期二Clinicalexperienceswithanewsemi-quantitativesolidphaseimmunoassayforrapidmeasurementof
procalcitonin.ClinChemLabMed.
2000Oct;38(10):989-95.現在是40頁\一共有59頁\編輯于星期二CritCareMed.
2006Jul;34(7):1996-2003.GlobaldiagnosticaccuracyoddsratiosforprocalcitoninProcalcitoninasadiagnostictestforsepsisincriticallyilladultsandaftersurgeryortrauma:asystematicreviewandmeta-analysisReviewArticle現在是41頁\一共有59頁\編輯于星期二APCTcut-offvalueof2ng/mLseparatedCandidasepsisfrombacterialsepsiswithasensitivityof92%,aspecificityof93%,andpositiveandnegativepredictivevaluesof94%.Thebestcut-offvalueforCRPtoseparatebacterialsepsisfromCandidasepsiswas100mg/L,withasensitivityof82%andaspecificityof53%ThecombinationofCRP(withacut-offvalueof100mg/L)andPCT(withacut-offof2ng/mL)didnotincreasesensitivityorspecificityforadiagnosisofCandidasepsis.Markersofsepsisandorgandysfunctionattimeofbloodculture.Dataareexpressedasmedian.
ProcalcitoninlevelsinsurgicalpatientsatriskofcandidemiaJInfect.2010Jun;60(6):425-30.現在是42頁\一共有59頁\編輯于星期二SerumlevelsofC-reactiveprotein(CRP)andprocalcitonin(PCT)onthestudieddaysaccordingtothepresenceofinvasivefungalinfection(IFI)orbacterialinfection(BI).EurJClinMicrobiolInfectDis.
2005
Apr;24(4):272-5.Valueofmeasuringserumprocalcitonin,C-reactiveprotein,andmannanantigenstodistinguishfungalfrombacterialinfections現在是43頁\一共有59頁\編輯于星期二SerumlevelsofC-reactiveprotein(CRP)andprocalcitonin(PCT)onthestudieddaysaccordingtothepresenceofinvasivefungalinfection(IFI)orbacterialinfection(BI).EurJClinMicrobiolInfectDis.
2005
Apr;24(4):272-5.Valueofmeasuringserumprocalcitonin,C-reactiveprotein,andmannanantigenstodistinguishfungalfrombacterialinfections成也蕭何,敗也蕭何現在是44頁\一共有59頁\編輯于星期二EurJClinInvest.2008Oct;38(10):784-5Acuteinfluenceofaerobicphysicalexerciseonprocalcitonin馬拉松也能升高PCT現在是45頁\一共有59頁\編輯于星期二Change2:DiagnosisUseoflowprocalcitoninlevelsorsimilarbiomarkerstoassisttheclinicianinthediscontinuation
ofempiricantibioticsinpatientswhoinitiallyappearedseptic,buthavenosubsequentevidenceofinfection(grade2C).DiagnMicrobiolInfectDis.2012Jul;73(3):221-7現在是46頁\一共有59頁\編輯于星期二PatientsrandomizedtothePCTgrouphadasignificantlyshortermedianICUlengthofstaythancontrolsubjects(3d;range,1–18d,vs.5d;range,1–30d,respectively;P=0.03),andatendencytostayforashorterperiodinthehospital(14d;range,5–64d,vs.21d;range,5–89d;P=0.16)AmJRespirCritCareMed.
2008
Mar1;177(5):498-505Useofprocalcitonintoshortenantibiotictreatmentdurationinsepticpatients:arandomizedtrial.現在是47頁\一共有59頁\編輯于星期二Lancet.
2010
Feb6;375(9713):463-74
現在是48頁\一共有59頁\編輯于星期二Change3:DiagnosisTimetopositivityofbloodculture(TTP)canpredictdifferentCandidaspeciesinsteadofpathogenconcentrationincandidemia現在是49頁\一共有59頁\編輯于星期二JClinMicrobiol.
2008
Jul;46(7):2222-6Timetobloodculturepositivityasamarkerforcatheter-relatedcandidemia現在是50頁\一共有59頁\編輯于星期二Timetobloodculturepositivityasamarkerforcatheter-relatedcandidemiaAccuracyofaTTPcutoffof30hforthediagnosisofCRCin50patientswithindwellingCVCsJClinMicrobiol.
2008
Jul;46(7):2222-6InpatientswithanindwellingCVC,definiteCRCgroupexhibitedsignificantlyshorterTTPthanculturesfromthenon-CRCgroup(17.32hversus37.75h;P0.009).現在是51頁\一共有59頁\編輯于星期二Timetobloodculturepositivityasamarkerforcatheter-relatedcandidemia
ThetimetodetectionofC.glabratawassignificantlylongerthanforotherCandidaspecies.Inconclusion,ourresultssuggestthattheTTPmaybeausefultoolintheevaluationofpatientswithcandidemiawhohaveanindwellingCVC,andinselectedcases,itmaysupportadecisiontoretainthecatheter.DISCUSSION現在是52頁\一共有59頁\編輯于星期二Timetopositivity
of
bloodcultures
of
differentCandidaspeciescausingfungaemia
ThemeanTTPforallisolatescausingcandidaemiawas25.9±24.9h.TheTTPforC.glabratawassignificantlylongerthantheTTPoftheotherspecies.Incontrast,theTTPofC.tropicaliswassignificantlyshorterthanthatoftheotherthreespecies.JMedMicrobiol.
2012
May;61(Pt5):701-4No.ofvialswithpositiveculturesTTP(hr)means+_SDCandidaalbicans8334.2+25.1Candidatropicalis4116.9+7.7Candidaglabrata3356.5+25.5Candidaparapsilosis1438.9+17.1現在是53頁\一共有59頁\編輯于星期二TimetopositivityofdifferentCandidaspeciesEurJClinMicrobiolInfectDis.
2013Feb1.
DepartmentofClinicalLaboratory,PekingUniversityFirstHospital,Beijing,China現在是54頁\一共有59頁\編輯于星期二1996-2005,Theappropriatenessofinitialantimicrobialtherapy,theclinicalinfectionsite,andrelevantpathogenswereretrospectivelydeterminedfor5,715patientswithsepticshockinthreecountries.Inappropriat
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯系上傳者。文件的所有權益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網頁內容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
- 4. 未經權益所有人同意不得將文件中的內容挪作商業(yè)或盈利用途。
- 5. 人人文庫網僅提供信息存儲空間,僅對用戶上傳內容的表現方式做保護處理,對用戶上傳分享的文檔內容本身不做任何修改或編輯,并不能對任何下載內容負責。
- 6. 下載文件中如有侵權或不適當內容,請與我們聯系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 度校企合作合同書(三):人才培養(yǎng)與交流
- 兒童健康食品供應合同
- 醫(yī)療中心服務合同樣本
- 環(huán)保工程項目內部承包合同范本
- 北京市全日制用工勞動合同模板
- 標準版租賃與購銷合同范本
- 雙方合作經營合同示范文本
- 城市住宅房屋買賣合同范本
- 文化機械產品用戶體驗評估方法考核試卷
- 工業(yè)機器人協(xié)作機器人技術考核試卷
- 醫(yī)院護理人文關懷實踐規(guī)范專家共識課件
- DeepSeek在自然災害預警中的潛力
- 2025年專利技術保密協(xié)議書模板
- 個人合伙開店合同范本
- 生而為贏自燃成陽-開學第一課發(fā)言稿
- 2024年設備監(jiān)理師考試題庫及答案參考
- 公司外派學習合同范例
- 2025年中國國投高新產業(yè)投資集團招聘筆試參考題庫含答案解析
- 安徽省合肥市包河區(qū) 2024-2025學年九年級上學期期末道德與法治試卷(含答案)
- 2024-2025學年小學美術一年級下冊(2024)嶺南版(2024)教學設計合集
- 《研學旅行課程設計》課件-研學課程設計計劃
評論
0/150
提交評論